P

Inventor

CHERUVALLATH ZACHARIA S

US16 patents
⚠️ This page may combine multiple inventors who share the name “CHERUVALLATH ZACHARIA S”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.

ISIS PHARMACEUTICALS INC

15 patents
US6242591B1Jun 5, 2001

Synthesis of sulfurized 2'-substituted oligonucleotides

ISIS PHARMACEUTICALS INC45 citations96
US5760209AJun 2, 1998

Protecting group for synthesizing oligonucleotide analogs

ISIS PHARMACEUTICALS INC72 citations96
US6326478B1Dec 4, 2001

Process for the synthesis of oligomeric compounds

ISIS PHARMACEUTICALS INC33 citations92
US6114519ASep 5, 2000

Synthesis of sulfurized oligonucleotides

ISIS PHARMACEUTICALS INC40 citations92
US5959099ASep 28, 1999

Protecting group for synthesizing oligonucleotide analogs

ISIS PHARMACEUTICALS INC21 citations92
US7227015B2Jun 5, 2007

Synthesis of sulfurized oligonucleotides

ISIS PHARMACEUTICALS INC11 citations84
US5902881AMay 11, 1999

Reagent useful for synthesizing sulfurized oligonucleotide analogs

ISIS PHARMACEUTICALS INC14 citations82
US5783690AJul 21, 1998

Protecting group for synthesizing oligonucleotide analogs

ISIS PHARMACEUTICALS INC16 citations82
US7378516B2May 27, 2008

Synthesis of sulfurized oligonucleotides

ISIS PHARMACEUTICALS INC8 citations74
US6677471B2Jan 13, 2004

Intermediates for the synthesis of oligonucleotide analogues

ISIS PHARMACEUTICALS INC4 citations74
US6521775B2Feb 18, 2003

Process for the synthesis of oligomeric compounds

ISIS PHARMACEUTICALS INC4 citations74
US6399756B1Jun 4, 2002

Process for the synthesis of oligomeric compounds

ISIS PHARMACEUTICALS INC6 citations74
US6040438AMar 21, 2000

Reagent useful for synthesizing sulfurized oligonucleotide analogs

ISIS PHARMACEUTICALS INC2 citations63
US7723511B2May 25, 2010

Synthesis of sulfurized oligonucleotides

ISIS PHARMACEUTICALS INC0 citations52
US6399831B1Jun 4, 2002

Reagent useful for synthesizing sulfurized oligonucleotide analogs

ISIS PHARMACEUTICALS INC0 citations52

METABASIS THERAPEUTICS INC

1 patent